Stockscreener 앱 받기
2.495
3.19%
-0.075
전일 마감가:
$2.57
열려 있는:
$2.59
하루 거래량:
750.43K
Relative Volume:
0.45
시가총액:
$132.33M
수익:
$832.00K
순이익/손실:
$-135.12M
주가수익비율:
-0.4097
EPS:
-6.09
순현금흐름:
$-124.69M
1주 성능:
+3.24%
1개월 성능:
+4.54%
6개월 성능:
+54.53%
1년 성능:
-56.73%
1일 변동 폭
$2.40
$2.63
1주일 범위
$2.28
$2.68
52주 변동 폭
$1.30
$5.83
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
명칭
Inovio Pharmaceuticals Inc
전화
(858) 410-3134
주소
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
INO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.49 | 136.58M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.12 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.45 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.58 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Piper Sandler | Overweight |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2024-01-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-11-09 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2022-11-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-19 | 재개 | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-12-29 | 재개 | Jefferies | Hold |
| 2021-09-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-24 | 개시 | Jefferies | Hold |
| 2021-03-23 | 개시 | BofA Securities | Neutral |
| 2021-02-12 | 개시 | Oppenheimer | Outperform |
| 2020-11-17 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2020-11-10 | 업그레이드 | ROTH Capital | Sell → Neutral |
| 2020-09-28 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-07-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-07-01 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2020-06-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-21 | 개시 | The Benchmark Company | Buy |
| 2020-04-30 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-03-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | 개시 | ROTH Capital | Buy |
| 2018-02-15 | 재확인 | Maxim Group | Buy |
| 2017-10-18 | 개시 | RBC Capital Mkts | Outperform |
| 2017-09-06 | 개시 | Citigroup | Buy |
| 2017-06-08 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | 재확인 | Maxim Group | Buy |
| 2017-03-16 | 업그레이드 | Maxim Group | Hold → Buy |
| 2017-03-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
모두보기
Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스
How risky is Inovio Pharmaceuticals Inc. stock now2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
What momentum indicators show for Inovio Pharmaceuticals Inc. stock2025 Pullback Review & AI Driven Stock Reports - newser.com
Will Inovio Pharmaceuticals Inc. bounce back from current supportJuly 2025 Gainers & Weekly Return Optimization Alerts - newser.com
Why hedge funds are buying Inovio Pharmaceuticals Inc. stockJuly 2025 PostEarnings & Technical Pattern Alert System - newser.com
Is Inovio Pharmaceuticals Inc. building a consolidation baseWeekly Investment Recap & Advanced Technical Signal Analysis - newser.com
Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Inovio Pharmaceuticals : American Academy of Otolaryngology – Head and Neck Surgery Annual Meeting Abstract - MarketScreener
Is Inovio Pharmaceuticals Inc. (GBM) stock prepared for digital transitionWeekly Gains Report & Community Verified Trade Alerts - newser.com
A activity2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
How to track smart money flows in Inovio Pharmaceuticals Inc.2025 Big Picture & Entry and Exit Point Strategies - newser.com
Inovio Pharmaceuticals' (INO) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Inovio Pharmaceuticals Inc. Stock Climbs 7.1%, Outperforms Peers - 富途牛牛
What drives Inovio Pharmaceuticals Inc GBM stock priceBollinger Bands Signals & Free Phenomenal Capital Appreciation - earlytimes.in
INOVIO Announces Equity Grant Under 2022 Inducement Plan - MSN
Can Akar Auto Industries Limited Achieve Earnings Growth in a SlowdownVWAP Trading Strategies & High Profit Investment Ideas - earlytimes.in
Inovio Pharmaceuticals (NASDAQ:INO) Share Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Can Inovio Pharmaceuticals Inc. stock beat analyst upgradesTrade Ideas & Fast Moving Stock Watchlists - newser.com
Is Inovio Pharmaceuticals Inc. (GBM) stock trading at attractive multiplesShare Buyback & Reliable Intraday Trade Plans - newser.com
When is the best time to exit Inovio Pharmaceuticals Inc.Product Launch & Verified Momentum Stock Alerts - newser.com
Will Inovio Pharmaceuticals Inc. stock remain a Wall Street favoriteJuly 2025 Macro Moves & Accurate Intraday Trade Tips - newser.com
Technical analysis overview for Inovio Pharmaceuticals Inc. stockGlobal Markets & Daily Technical Forecast Reports - newser.com
INOVIO Reports Inducement Grant Under Inducement Plan - Eastern Progress
Is Inovio Pharmaceuticals Inc. stock a top momentum play2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Inovio Pharmaceuticals Inc. stock trendline breakdownWeekly Trade Review & Detailed Earnings Play Alerts - newser.com
What hedge fund moves indicate for Inovio Pharmaceuticals Inc. (GBM) stock2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Heatmap analysis for Inovio Pharmaceuticals Inc. and competitorsGold Moves & Growth Focused Stock Pick Reports - newser.com
INOVIO to Present Key Data on DNA Medicines at Global Scientific Conferences - MyChesCo
Certain Stock Options of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. - MarketScreener
Certain Common Stock of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. - MarketScreener
Non-Viral Transfection Reagents Industry Report 2025, with Profiles of Altogen Biosystems, BEX, BTX, Celsion, Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene, OZ Biosciences & MoreResearchAndMarkets.com - The AI Journal
What analysts say about Inovio Pharmaceuticals Inc GBM stockVolume Profile Analysis & Watch These Before They Go Viral - earlytimes.in
Key Metrics Every Investor Should Know About Soni Medicare LimitedProtective Put Strategies & Exceptional Capital Growth - earlytimes.in
How moving averages guide Inovio Pharmaceuticals Inc. tradingMarket Weekly Review & Weekly Top Stock Performers List - newser.com
Inovio Pharmaceuticals Inc (INO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.19%
자본화:
|
볼륨(24시간):